Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Nils Winkelmann,
Matthew Rose-Zerilli,
Jade Forster,
Marina Parry,
Anton Parker,
Anne Gardiner,
Zadie Davies,
Andrew J. Steele,
Helen Parker,
Nicholas C.P. Cross,
David G. Oscier,
Jonathan C. Strefford
Affiliations
Nils Winkelmann
Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK;Klinik für Innere Medizin II, Universitätsklinikum Jena, Germany
Matthew Rose-Zerilli
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Jade Forster
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Marina Parry
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Anton Parker
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK;Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK
Anne Gardiner
Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK
Zadie Davies
Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK
Andrew J. Steele
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Helen Parker
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Nicholas C.P. Cross
Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK;Human Development and Health, Faculty of Medicine, University of Southampton, UK
David G. Oscier
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK;Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK
Jonathan C. Strefford
Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, UK